With 232, Washington Plans To Tax Your Pacemaker
The Trump administration has launched a Section 232 investigation into imported medical products, citing national security and supply-chain resilience. The broad scope includes medical equipment, protective gear, and advanced health technologies. Critics argue the move effectively imposes a tax on Americans and could increase healthcare costs.
- ▪The Commerce Department is conducting a Section 232 investigation into imported medical products.
- ▪The probe covers medical equipment, personal protective equipment, and various health technologies.
- ▪The investigation's wide scope includes robotics and critical medical devices used in modern healthcare.
- ▪This action is framed as enhancing supply-chain resilience but may lead to higher healthcare costs for patients.
Opening excerpt (first ~120 words) tap to expand
The Trump administration has opened a Section 232 national security investigation into imported medical products. It is being sold as a supply-chain resilience effort. But it is a tax on Americans that raises healthcare costs for patients. The Commerce Department’s probe covers medical equipment, personal protective equipment, and a wide range of health technologies used every day in hospitals and clinics. The scope is so sweeping that it now threatens robotics and medical devices—the tools modern medicine depends on. Read Full Article »
Excerpt limited to ~120 words for fair-use compliance. The full article is at RealClear Markets.